Article
Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice.
Antioxidants & redox signaling - 15 Oct 2012
Cho Hye-Youn, van Houten Bennett, Wang Xuting, Miller-DeGraff Laura, Fostel Jennifer, Gladwell Wesley, Perrow Ligon, Panduri Vijayalakshmi, Kobzik Lester, Yamamoto Masayuki, Bell Douglas A, Kleeberger Steven R
Abstract excerpt
AIMS: Nrf2 is an essential transcription factor for protection against oxidant disorders. However, its role in organ development and neonatal disease has received little attention. Therapeutically administered oxygen has been considered to contribute to bronchopulmonary dysplasia (BPD) in prematurity. The current study was performed to determine Nrf2-mediated molecular events during saccular-to-alveolar lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
